Case Report: When inotropy backfires—dobutamine-associated eosinophilic myocarditis

Eosinophilic myocarditis (EM) is a rare form of myocarditis that is often triggered by drug hypersensitivity reactions. We describe the case of a 55-year-old man who presented with cardiogenic shock that rapidly progressed despite dual inotropic therapy, ultimately requiring left ventricular assist device implantation. A left ventricular apical core biopsy demonstrated eosinophilic infiltration consistent with EM. After comprehensive evaluation of the possible etiologies, dobutamine was identified as the most likely offending agent. Following discontinuation of dobutamine and initiation of corticosteroid therapy, ventricular function and hemodynamics improved, supporting a diagnosis of dobutamine-associated EM. Clinicians should consider drug-induced EM in patients with refractory cardiogenic shock receiving dobutamine. Alternative inotropic agents such as milrinone or epinephrine should be considered.

Authors

Institutions

Publication Details

Journal
Frontiers in Cardiovascular Medicine
Published
2026-04-30
DOI
https://doi.org/10.3389/fcvm.2026.1781601
Primary Topic
Eosinophilic Disorders and Syndromes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Case Report: When inotropy backfires—dobutamine-associated eosinophilic myocarditis

Sahitya Allam, Manjula Ananthram, Erik Sørensen, Abdullah Aljudaibi et al.
Frontiers in Cardiovascular Medicine
Eosinophilic Disorders and Syndromes
article

Case Report: When inotropy backfires—dobutamine-associated eosinophilic myocarditis

Sahitya Allam, Manjula Ananthram, Erik Sørensen, Abdullah Aljudaibi, Lo Tamburro, Gautam Ramani, Bartley P. Griffith, Jose-Alejandro Almario, Kristi Dutta, Lynn Dees
article en

Abstract

Eosinophilic myocarditis (EM) is a rare form of myocarditis that is often triggered by drug hypersensitivity reactions. We describe the case of a 55-year-old man who presented with cardiogenic shock that rapidly progressed despite dual inotropic therapy, ultimately requiring left ventricular assist device implantation. A left ventricular apical core biopsy demonstrated eosinophilic infiltration consistent with EM. After comprehensive evaluation of the possible etiologies, dobutamine was identified as the most likely offending agent. Following discontinuation of dobutamine and initiation of corticosteroid therapy, ventricular function and hemodynamics improved, supporting a diagnosis of dobutamine-associated EM. Clinicians should consider drug-induced EM in patients with refractory cardiogenic shock receiving dobutamine. Alternative inotropic agents such as milrinone or epinephrine should be considered.

Frontiers in Cardiovascular MedicineVol. 13
University of Maryland, Baltimore (US), University of Maryland Medical Center (US), Cooper University Hospital (US), University of Pittsburgh Medical Center (US)
Good health and well-being
Openalex Percentile: Top 10%
Eosinophilic Disorders and Syndromes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Case Report: When inotropy backfires—dobutamine-associated eosinophilic myocarditis — Sahitya Allam, Manjula Ananthram, et al. · Frontiers in Cardiovascular Medicine (2026) | TGRS Research Map | TGRS